PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
AIDS Research Alliance

Press Release

Share      Blog

Receive press releases from AIDS Research Alliance: By Email PDF Version RSS Feeds:

Dr. David Hardy Joins AIDS Research Alliance's Board; Brings 30+ Years HIV Medical Experience


Dr. David Hardy Joins AIDS Research Alliance's Board; Brings 30+ Years HIV Medical Experience
Los Angeles, CA, June 01, 2013 --(PR.com)-- AIDS Research Alliance is pleased to announce the addition of a very experienced HIV researcher and physician to their Board of Directors. Dr. David Hardy, the Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center, and Professor of Medicine at the David Geffen School of Medicine at UCLA, has been a supporter of AIDS Research Alliance for many years. As a Board member, he will bring more than 30 years of HIV medical experience -- first treating HIV-positive patients, and then research. Currently, Dr. Hardy performs clinical trials (phase II and III) of investigational antiretroviral agents for treatment of HIV infection, and of therapeutic vaccines for HIV infection.

Early in the AIDS epidemic, Dr. Hardy completed a fellowship in infectious diseases/clinical immunology at the UCLA School of Medicine, mentored by Michael Gottlieb, MD, also a long-time friend to ARA, as well as the physician who reported the first cases of AIDS. Later, Dr. Hardy completed post-doctoral training in HIV laboratory research with Irvin Chen, PhD at the UCLA School of Medicine.

“I am excited about becoming a member of the Board of Directors at AIDS Research Alliance,” said Dr. Hardy. “I am interested in the organization’s work on the HIV reservoirs, particularly its work on prostratin. The research community is focusing more time and resources on the reservoirs, and the possibility of eradicating them, which is what prostratin, as part of a larger cure strategy, aims to do.”

“Further,” he continued, “I hope that my background in infectious disease will be helpful to AIDS Research Alliance as it expands its mission to include a broad portfolio of infectious diseases.”

“We are honored to welcome Dr. Hardy, a medical professional with over three decades of HIV/AIDS experience and knowledge, to our Board,” said ARA CEO Carolyn Carlburg. “Dr. Hardy was the keynote speaker at our 2012 World AIDS Day Concert. He will continue to share his expertise and perspective with the organization – now, through his role on the Board of Directors. We look forward to working with him, and to leveraging his knowledge for maximum results.”

Dr. Hardy chairs the Education Committee of the American Academy of HIV Medicine (AAHIVM), and serves as editor-in-chief of their Fundamentals of HIV Medicine for the HIV Specialist. He also serves on the Board of Directors of the HIV Medical Association (HIVMA).

Meet the rest of ARA’s Board of Directors: http://aidsresearch.org/about/leadership/board/
Contact Information
AIDS Research Alliance
Emma Brownell
310.360.3879
Contact
www.aidsresearch.org

Click here to view the list of recent Press Releases from AIDS Research Alliance
Promote Your Business